RCG
BIIB icon

Rock Creek Group’s Biogen BIIB Stock Holding History

Rock Creek Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20
Closed -$5.14K – 78
2023
Q3 		$5.14K Buy
20
+12
+150% +$3.21K ﹤0.01% 184
2023
Q2 		$2.28K Buy
+8
New +$2.38K ﹤0.01% 172
2022
Q4 		– Sell
-10
Closed -$3K – 164
2022
Q3 		$3K Sell
10
-16
-62% -$3.4K ﹤0.01% 165
2022
Q2 		$5K Hold
26
– – ﹤0.01% 156
2022
Q1 		$5K Buy
+26
New +$5.65K ﹤0.01% 169
2021
Q3 		– Sell
-3
Closed -$1K – 179
2021
Q2 		$1K Sell
3
-7
-70% -$2.12K ﹤0.01% 182
2021
Q1 		$3K Buy
+10
New +$2.7K ﹤0.01% 213
2020
Q4 		– Sell
-489
Closed -$139K – 174
2020
Q3 		$139K Sell
489
-285
-37% -$79.5K 0.07% 149
2020
Q2 		$207K Buy
774
+24
+3% +$7.21K 0.11% 134
2020
Q1 		$237K Buy
+750
New +$228K 0.13% 88
2019
Q3 		– Sell
-1,283
Closed -$300K – 113
2019
Q2 		$300K Sell
1,283
-113
-8% -$26.1K 0.14% 97
2019
Q1 		$330K Sell
1,396
-377
-21% -$119K 0.15% 72
2018
Q4 		$534K Buy
1,773
+840
+90% +$268K 0.23% 68
2018
Q3 		$330K Buy
+933
New +$321K 0.14% 80

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Rock Creek Group's BIIB Position: Q4 2023 in Review

Rock Creek Group sold out of Biogen (BIIB) in Q4 2023, closing a stake of 20 shares — an estimated $5.14K sold.

Rock Creek Group first reported a position in BIIB in Q3 2018 and held it in 14 quarters. The position peaked at $534K in Q4 2018. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

  • Rock Creek Group reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
  • Rock Creek Group sold 20 Biogen shares in Q4 2023, an estimated $5.14K.
  • Rock Creek Group first reported a position in Biogen in Q3 2018 and held it in 14 quarters.
  • Rock Creek Group's Biogen position peaked at $534K in Q4 2018.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on Rock Creek Group's 13F filing for Q4 2023, filed 13 Feb 2024.